{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T04:45:35Z","timestamp":1780980335972,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.neurol.2017.03.036","type":"journal-article","created":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T23:01:15Z","timestamp":1494284475000},"page":"396-405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Descriptive study of the parkinsonian population in the north of France: Epidemiological analysis and healthcare consumption"],"prefix":"10.1016","volume":"173","author":[{"given":"N.","family":"Carriere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Verloop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Fontaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Krystkowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-M.","family":"Defebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Defebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"January (1)","key":"10.1016\/j.neurol.2017.03.036_bib0180","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neurol.2015.09.012","article-title":"Epidemiology of Parkinson's disease","volume":"172","author":"Elbaz","year":"2016","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.neurol.2017.03.036_bib0185","unstructured":"Direction de la recherche, des \u00e9tudes, de l\u2019\u00e9valuation et des statistiques. L\u2019\u00e9tat de sant\u00e9 de la population en France, rapport 2015. Minist\u00e8re des affaires sociales, de la sant\u00e9 et des droits de femmes; 2015."},{"issue":"March (3)","key":"10.1016\/j.neurol.2017.03.036_bib0190","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/ene.12592","article-title":"Parkinson's disease incidence and prevalence assessment in France using the national healthcare insurance database","volume":"22","author":"Blin","year":"2015","journal-title":"Eur J Neurol"},{"issue":"January (5)","key":"10.1016\/j.neurol.2017.03.036_bib0195","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","article-title":"Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030","volume":"68","author":"Dorsey","year":"2007","journal-title":"Neurology"},{"issue":"November (9192)","key":"10.1016\/j.neurol.2017.03.036_bib0200","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(99)04137-9","article-title":"Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study","volume":"354","author":"Schrag","year":"1999","journal-title":"The Lancet"},{"issue":"August (4)","key":"10.1016\/j.neurol.2017.03.036_bib0205","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000078506","article-title":"Epidemiology of multiple system atrophy: a prevalence and pilot risk factor study in Aquitaine, France","volume":"23","author":"Chrysostome","year":"2004","journal-title":"Neuroepidemiology"},{"issue":"February (2)","key":"10.1016\/j.neurol.2017.03.036_bib0210","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/jnnp-2012-302500","article-title":"Incidence and prevalence of multiple system atrophy: a nationwide study in Iceland","volume":"84","author":"Bjornsdottir","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"July (Pt 7)","key":"10.1016\/j.neurol.2017.03.036_bib0215","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/brain\/124.7.1438","article-title":"The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK","volume":"124","author":"Nath","year":"2001","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.neurol.2017.03.036_bib0220","unstructured":"Strat\u00e9gie Nationale de Sant\u00e9. Plan maladies neuro-d\u00e9g\u00e9n\u00e9ratives 2014\u20132019. Minist\u00e8re des affaires sociales, de la sant\u00e9 et des droits de femmes; 2014."},{"issue":"August (3)","key":"10.1016\/j.neurol.2017.03.036_bib0225","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/aje\/kwr081","article-title":"Prediction model of Parkinson's disease based on antiparkinsonian drug claims","volume":"174","author":"Moisan","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"July (1)","key":"10.1016\/j.neurol.2017.03.036_bib0230","first-page":"49","article-title":"Estimate of parkinsonism prevalence through drug prescription histories in the Province of Rome","volume":"92","author":"Menniti-Ippolito","year":"1995","journal-title":"Italy. Acta Neurol Scand"},{"issue":"May (3)","key":"10.1016\/j.neurol.2017.03.036_bib0235","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/mds.870130305","article-title":"Prevalence of Parkinson's disease in Northwestern Italy: comparison of tracer methodology and clinical ascertainment of cases","volume":"13","author":"Chi\u00f2","year":"1998","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"November (6)","key":"10.1016\/j.neurol.2017.03.036_bib0240","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/pds.624","article-title":"Estimation of incidence and prevalence of Parkinson's disease in the elderly using pharmacy records","volume":"10","author":"van de Vijver","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"February (3)","key":"10.1016\/j.neurol.2017.03.036_bib0245","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/mds.22359","article-title":"Geographical difference in Parkinson's disease prevalence within West Scotland","volume":"24","author":"Newman","year":"2009","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"January (1)","key":"10.1016\/j.neurol.2017.03.036_bib0250","first-page":"32","article-title":"The prevalence of Parkinson's disease in an Arab population, Wadi Ara, Israel","volume":"12","author":"Masalha","year":"2010","journal-title":"Isr Med Assoc J IMAJ"},{"issue":"March (4)","key":"10.1016\/j.neurol.2017.03.036_bib0255","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/mds.21299","article-title":"Accuracy of Medicare claims data in identifying Parkinsonism cases: comparison with the Medicare current beneficiary survey","volume":"22","author":"Noyes","year":"2007","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"January (1)","key":"10.1016\/j.neurol.2017.03.036_bib0260","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/mds.22283","article-title":"Optimizing algorithms to identify Parkinson's disease cases within an administrative database","volume":"24","author":"Szumski","year":"2009","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"10.1016\/j.neurol.2017.03.036_bib0265","series-title":"M\u00e9thodologie g\u00e9n\u00e9rale de la cartographie des pathologies d\u00e9velopp\u00e9e par la CnamTS pour les ann\u00e9es 2012\u20132013\u20132014 (version dite G3 de la cartographie) [Internet]. CnamTS","author":"Caisse nationale d\u2019Assurance maladie","year":"2016"},{"key":"10.1016\/j.neurol.2017.03.036_bib0270","unstructured":"INSEE. Population \u2013 Donn\u00e9es d\u00e9taill\u00e9es de la situation d\u00e9mographique en 2013 [Internet]. Available from: http:\/\/www.insee.fr\/fr\/themes\/detail.asp?ref_id=ir-irsocsd2013&page=irweb\/irsocsd2013\/dd\/pyramide\/pyramide_aide.htm [cited 27.04.16]."},{"issue":"November (13)","key":"10.1016\/j.neurol.2017.03.036_bib0275","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/mds.25945","article-title":"The prevalence of Parkinson's disease: a systematic review and meta-analysis","volume":"29","author":"Pringsheim","year":"2014","journal-title":"Mov Disord"},{"issue":"August (4)","key":"10.1016\/j.neurol.2017.03.036_bib0280","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.euroneuro.2005.04.007","article-title":"Prevalence and incidence of Parkinson's disease in Europe","volume":"15","author":"von Campenhausen","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"issue":"August (2)","key":"10.1016\/j.neurol.2017.03.036_bib0285","first-page":"111","article-title":"Prevalence of Parkinson's disease in the elderly: a population study in Gironde, France","volume":"90","author":"Tison","year":"1994","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"10.1016\/j.neurol.2017.03.036_bib0290","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000109796","article-title":"Prevalence of neurological disorders in Haute-Vienne department (Limousin region-France)","volume":"14","author":"Munoz","year":"1995","journal-title":"Neuroepidemiology"},{"issue":"December (16)","key":"10.1016\/j.neurol.2017.03.036_bib0295","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1002\/mds.22829","article-title":"Accuracy of Parkinson's disease diagnosis in 610 general practice patients in the West of Scotland","volume":"24","author":"Newman","year":"2009","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"May (5)","key":"10.1016\/j.neurol.2017.03.036_bib0300","first-page":"783","article-title":"Reliability of administrative data for the identification of Parkinson's disease cohorts","volume":"36","author":"Baldacci","year":"2015","journal-title":"Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol"},{"issue":"December (6)","key":"10.1016\/j.neurol.2017.03.036_bib0305","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/ana.23687","article-title":"Meta-analysis of early nonmotor features and risk factors for Parkinson disease","volume":"72","author":"Noyce","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2017.03.036_bib0310","series-title":"Insee Flash Nord-Pas-de-Calais N\u00b05 \u2013 Nord Pas-De-Calais et Picardie: l\u2019influence des grandes aires urbaines [Internet]","author":"Degore","year":"2015"},{"key":"10.1016\/j.neurol.2017.03.036_bib0315","series-title":"Guide du Parcours de Soins Maladie de Parkinson [Internet]","author":"Haute Autorit\u00e9 de Sant\u00e9","year":"2014"},{"key":"10.1016\/j.neurol.2017.03.036_bib0320","unstructured":"INSEE. Estimation de population par r\u00e9gion, sexe et grande classe d\u2019\u00e2ge \u2013 Ann\u00e9es 1975 \u00e0 2015 [Internet]. Available from: http:\/\/www.insee.fr\/fr\/ppp\/bases-de-donnees\/donnees-detaillees\/estim-pop\/estim-pop-reg-sexe-gca-1975-2015.xls [cited 19.07.16]"},{"key":"10.1016\/j.neurol.2017.03.036_bib0325","series-title":"Atlas de la d\u00e9mographie m\u00e9dicale en France \u2013 situation au 1er janvier 2014","author":"Bouet","year":"2014"},{"issue":"January (1)","key":"10.1016\/j.neurol.2017.03.036_bib0330","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1468-1331.2011.03402.x","article-title":"Oro-buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson's disease: preliminary analysis from the French COPARK cohort","volume":"19","author":"Perez-Lloret","year":"2012","journal-title":"Eur J Neurol"},{"issue":"May (3)","key":"10.1016\/j.neurol.2017.03.036_bib0335","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/mds.1090","article-title":"Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature","volume":"16","author":"Ahlskog","year":"2001","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"July (7)","key":"10.1016\/j.neurol.2017.03.036_bib0340","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/jamaneurol.2014.753","article-title":"Prevalence, determinants, and effect on quality of life of freezing of gait in parkinson disease","volume":"71","author":"Perez-Lloret","year":"2014","journal-title":"JAMA Neurol"},{"issue":"November (Pt 11)","key":"10.1016\/j.neurol.2017.03.036_bib0345","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1093\/brain\/123.11.2297","article-title":"Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study","volume":"123","author":"Schrag","year":"2000","journal-title":"Brain J Neurol"},{"issue":"January (1)","key":"10.1016\/j.neurol.2017.03.036_bib0350","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1468-1331.2012.03866.x","article-title":"Summary of the recommendations of the EFNS\/MDS-ES review on therapeutic management of Parkinson's disease","volume":"20","author":"Ferreira","year":"2013","journal-title":"Eur J Neurol"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003537871630203X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003537871630203X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:29:37Z","timestamp":1719188977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003537871630203X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S003537871630203X"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2017.03.036","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Descriptive study of the parkinsonian population in the north of France: Epidemiological analysis and healthcare consumption","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2017.03.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}